Richard Watts,
Vice President,
QIAGEN
Richard Watts is Vice President of Business Development for Companion Diagnostic Partnerships for the Americas. Working to establish collaborations and diagnostic development programs with pharmaceutical companies, Richard consults on technology, clinical and regulatory aspects that support the strategic, operational and commercial elements of drug-diagnostic co-development programs. Richard has worked in partnership with pharma for the pre-launch and launch of KRAS and EGFR testing on a global basis. He has also structured many other companion diagnostic co-development programs, master collaboration agreements and other transactional deals. Richard also has a role in the scouting and diligence of new enabling technologies for diagnostic application. Prior to his position in business development he managed and implemented QIAGEN’s marketing strategy in the pharmaceutical sector with a focus on translational medicine and pharmacogenomics. Before joining QIAGEN Richard held senior managerial, commercial and technical positions at Invitrogen, Nanogen, Packard and Bio-Rad. Richard is a fellow of the royal society of medicine and graduated in molecular and cellular biology from the University of Bath.
|
|
|